# US 2010/0168651 A1 · Devices, systems, and methods for myocardial infarct border zone reinforcement

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0168651 A1
- Document ID: US20100168651A1
- Status: Published application
- Kind: A1
- Application number: 12/723,015
- Filed: 2010-03-12
- Published: 2010-07-01
- Earliest claimed: 2009-10-21
- Assignees: CVDevices, LLC
- Inventors: Ghassan S. Kassab; Jose A. Navia, SR.
- Web page: https://patentgrep.com/patent/US20100168651A1

## CPC

- A61M 25/0147: {with movable mechanical means, e.g. pull wires}
- A61M 60/191: mechanically acting upon the outside of the patient's native heart, e.g. compressive structures placed around the heart
- A61M 60/289: Devices for mechanical circulatory actuation assisting the residual heart function by means mechanically acting upon the patient's native heart or blood vessel structure, e.g. direct cardiac compression [DCC] devices
- A61M 60/468: the force acting on the actuation means being hydraulic or pneumatic
- A61M 60/508: Electronic control means, e.g. for feedback regulation
- A61M 60/865: Devices for guiding or inserting pumps or pumping devices into the patient's body
- A61B 17/0057: {Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect (sutures A61B17/04; closing rectum or urethra near body surface A61F2/0009)}
- A61B 90/37: {Surgical systems with images on a monitor during operation}
- A61B 2017/00247: {Making holes in the wall of the heart, e.g. laser Myocardial revascularization}
- A61B 2017/003: {Steerable}
- A61B 2017/00584: {Clips}
- A61B 2017/00592: {Elastic or resilient implements}
- A61B 2017/00601: {Implements entirely comprised between the two sides of the opening}
- A61B 2017/00606: {Implements H-shaped in cross-section, i.e. with occluders on both sides of the opening}
- A61B 2017/00628: {T-shaped occluders}
- A61B 2017/306: {holding by means of suction}
- A61B 2017/308: {with suction cups}
- A61B 2018/00392: {Transmyocardial revascularisation}
- A61M 25/00: Catheters; Hollow probes (dilators A61M29/00; {peritoneal catheters A61M1/285; tracheal tubes A61M16/04; for drainage A61M27/00; for uterus, vagina or rectum A61M31/00} ; for measuring or testing A61B; {materials for catheters A61L29/00})
- A61M 25/003: {characterized by features relating to least one lumen located at the distal part of the catheter, e.g. filters, plugs or valves (catheter tips A61M25/0067)}
- A61M 25/0054: {with regions for increasing flexibility}
- A61M 25/0074: {Dynamic characteristics of the catheter tip, e.g. openable, closable, expandable or deformable}
- A61M 25/0084: {being one or more injection needles}
- A61M 25/0136: {Handles therefor}
- A61M 25/0141: {having flexible regions as a result of using materials with different mechanical properties}
- A61M 25/06: Body-piercing guide needles or the like
- A61M 2025/0036: {with more than four lumina}
- A61M 2025/0039: {characterized by lumina being arranged coaxially}
- A61M 2025/004: {characterized by lumina being arranged circumferentially}
- A61M 2025/0089: {Single injection needle protruding axially, i.e. along the longitudinal axis of the catheter, from the distal tip}
- A61M 2025/0096: {being laterally outward extensions or tools, e.g. hooks or fibres}
- A61M 2025/015: {Details of the distal fixation of the movable mechanical means}
- A61M 2025/0681: {Systems with catheter and outer tubing, e.g. sheath, sleeve or guide tube}
- A61M 2205/32: with radio-opaque indicia
- A61M 2205/33: Controlling, regulating or measuring
- A61M 2205/3303: Using a biosensor
- A61M 2205/3331: Pressure; Flow
- A61M 2210/122: Pericardium
- A61M 2210/125: Heart
- A61M 2230/005: Parameter used as control input for the apparatus
- A61N 1/0587: {Epicardial electrode systems; Endocardial electrodes piercing the pericardium}
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

Devices, systems, and methods for myocardial infarct border zone reinforcement. In at least one embodiment of a suction/infusion catheter for facilitating myocardial infarct border zone reinforcement, the catheter comprises one or more apertures defined along a portion of the catheter at or near a distal end of the catheter, a first configuration when the suction/infusion catheter is at least partially extended from a delivery catheter, and a second configuration when the at least one suction/infusion catheter is positioned within the delivery catheter, the second configuration different from the first configuration, wherein the suction/infusion catheter, when introduced into a pericardial space surrounding a heart at or near a myocardial infarct border zone, is operable to inject a glue-like substance through a lumen of the suction/infusion catheter and out from the one or more apertures to deliver the glue-like substance into the pericardial space at or near the myocardial infarct border zone.

## Claims

### Claim 1

A method of myocardial infarct border zone reinforcement, the method comprising the steps of:
introducing at least one suction/infusion catheter having a lumen therethrough to a pericardial space surrounding a heart at or near a site of myocardial infarct border zone, the at least one suction/infusion catheter comprising:
one or more apertures defined along a portion of the at least one suction/infusion catheter at or near a distal end of the at least one suction/infusion catheter;
a first configuration when the at least one suction/infusion catheter is at least partially extended from a delivery catheter; and
a second configuration when the at least one suction/infusion catheter is positioned within the delivery catheter, the second configuration different from the first configuration;
injecting a glue-like substance through the lumen of the at least one suction/infusion catheter and out from the one or more apertures to deliver the glue-like substance into the pericardial space at or near the myocardial infarct border zone; and
injecting magnetic cells through the lumen of the at least one suction/infusion catheter and out from the one or more apertures to deliver the magnetic cells into the pericardial space at or near the myocardial infarct border zone, wherein the magnetic cells are attracted to the glue-like substance, and wherein the magnetic cells provide structural support to the myocardial infarct border zone.

### Claim 2 (depends on 1)

The method of claim 1, wherein the glue-like substance comprises a biologic glue.

### Claim 3 (depends on 2)

The method of claim 2, wherein the biologic glue comprises liposomes containing magnetic particles.

### Claim 4 (depends on 3)

The method of claim 3, wherein the liposomes comprise a peptide attached to an outer surface of the liposomes.

### Claim 5 (depends on 4)

The method of claim 4, wherein the peptide comprises an arginine-glycine-apsartate peptide.

### Claim 6 (depends on 1)

The method of claim 1, wherein the glue-like substance binds to a myocardial infarct border zone.

### Claim 7 (depends on 1)

The method of claim 1, wherein the magnetic cells comprise biologic cells.

### Claim 8 (depends on 7)

The method of claim 7, wherein the biologic cells comprise dermal fibroblasts.

### Claim 9 (depends on 8)

The method of claim 8, wherein the dermal fibroblasts contain magnetic particles.

### Claim 10 (depends on 1)

The method of claim 1, wherein the magnetic cells are attracted to a peptide attached to the glue-like substance.

### Claim 11 (depends on 1)

The method of claim 1, wherein the magnetic cells are magnetically attracted to the glue like substance.

### Claim 12 (depends on 1)

The method of claim 1, wherein the magnetic cells, when positioned within the pericardial space at or near the myocardial infarct border zone, may reproduce to form a tissue, said tissue providing structural support at the myocardial infarct border zone.

### Claim 13 (depends on 1)

The method of claim 1, wherein the first configuration comprises a coiled configuration, and wherein the second configuration comprises an uncoiled configuration.

### Claim 14 (depends on 1)

The method of claim 1, wherein the step of introducing the at least one suction/infusion catheter is performed using a pericardial sac approach.

### Claim 15 (depends on 1)

The method of claim 1, wherein the step of introducing the at least one suction/infusion catheter is performed by introducing the at least one suction/infusion catheter into a jugular vein, through a superior vena cava, and into the pericardial space.

### Claim 16 (depends on 1)

The method of claim 1, wherein the step of introducing the at least one suction/infusion catheter is performed by introducing the at least one suction/infusion catheter into a femoral vein, through an inferior vena cava, and into the pericardial space.

### Claim 17 (depends on 1)

The method of claim 1, wherein the myocardial infarct border zone is at a left ventricle of the heart, and wherein the step of introducing the at least one suction/infusion catheter comprises the introduction of the at least one suction/infusion catheter into the pericardial space at or near the left ventricle of the heart.

### Claim 18 (depends on 1)

The method of claim 1, wherein the at least one suction/infusion catheter further comprises a guide wire positioned at the distal end of the at least one suction/infusion catheter, wherein the guide wire facilitates introduction of the at least one suction/infusion catheter in the step of introducing the at least one suction/infusion catheter.

### Claim 19 (depends on 1)

The method of claim 1, wherein the step of introducing the at least one suction/infusion catheter further comprises extending the at least one suction/infusion catheter from the delivery catheter to allow for an increased surface area of at least one suction/infusion catheter to be positioned at or near the myocardial infarct border zone.

### Claim 20 (depends on 1)

The method of claim 1, further comprising the step of introducing an occluder within the lumen of the at least one suction/infusion catheter, wherein the occluder may partially or completely block one or more apertures of the at least one suction/infusion catheter.

### Claim 21 (depends on 1)

The method of claim 1, wherein the at least one suction/infusion catheter further comprises a support wire positioned along at least part of a length of the at least one suction/infusion catheter.

### Claim 22 (depends on 21)

The method of claim 21, wherein the support wire facilitates the step of introducing at least one suction/catheter into the pericardial space.

### Claim 23 (depends on 21)

The method of claim 21, further comprising the step of introducing an occluder within the lumen of the at least one suction/infusion catheter, wherein the step of introducing an occluder is facilitated by the support wire.

### Claim 24

A suction/infusion catheter for facilitating myocardial infarct border zone reinforcement, comprising:
one or more apertures defined along a portion of a suction/infusion catheter at or near a distal end of the suction/infusion catheter;
a first configuration when the suction/infusion catheter is at least partially extended from a delivery catheter; and
a second configuration when the suction/infusion catheter is positioned within the delivery catheter, the second configuration different from the first configuration;
wherein the suction/infusion catheter, when introduced into a pericardial space surrounding a heart at or near a myocardial infarct border zone, is operable to inject a glue-like substance through a lumen of the suction/infusion catheter and out from the one or more apertures to deliver the glue-like substance into the pericardial space at or near the myocardial infarct border zone.

### Claim 25 (depends on 24)

The suction/infusion catheter of claim 24, wherein the suction/infusion catheter is further operable to inject magnetic cells through the lumen of the suction/infusion catheter and out from the one or more apertures to deliver the magnetic cells into the pericardial space at or near the myocardial infarct border zone, wherein the magnetic cells are attracted to the glue-like substance, and wherein the magnetic cells provide structural support to the myocardial infarct border zone.

### Claim 26 (depends on 24)

The suction/infusion catheter of claim 24, wherein the first configuration of the memory comprises a coiled configuration.

### Claim 27 (depends on 26)

The suction/infusion catheter of claim 26, wherein the coiled configuration comprises a racquet shape.

### Claim 28 (depends on 24)

The suction/infusion catheter of claim 24, wherein the first configuration comprises a coiled configuration, and wherein the second configuration comprises an uncoiled configuration.

### Claim 29 (depends on 24)

The suction/infusion catheter of claim 24, further comprising a guide wire positioned at the distal end of the suction/infusion catheter, wherein the guide wire facilitates introduction of the suction/infusion catheter into the pericardial space.

### Claim 30 (depends on 24)

The suction/infusion catheter of claim 24, further comprising an occluder positioned within a lumen of the suction/infusion catheter, wherein the occluder may partially or completely block one or more apertures of the suction/infusion catheter.

### Claim 31 (depends on 24)

The suction/infusion catheter of claim 24, further comprising a support wire positioned along at least part of a length of the suction/infusion catheter.

### Claim 32 (depends on 31)

The suction/infusion catheter of claim 31, wherein the support wire facilitates introduction of the suction/catheter into the pericardial space.

### Claim 33 (depends on 31)

The suction/infusion catheter of claim 31, wherein the support wire is used to define the memory comprising the first configuration.

### Claim 34 (depends on 31)

The suction/infusion catheter of claim 31, wherein the support wire provides rigidity to the suction/infusion catheter.

### Claim 35

A system for facilitating myocardial infarct border zone reinforcement, comprising:
an engagement catheter having a proximal end, a distal end, and a lumen positioned therethrough;
a delivery catheter having a proximal end, a distal end, and a lumen positioned therethrough, the delivery catheter positioned at least partially within the lumen of the engagement catheter; and
at least one suction/infusion catheter positioned at least partially within the lumen of the delivery catheter, the at least one suction/infusion catheter comprising:
one or more apertures defined along a portion of the at least one suction/infusion catheter at or near a distal end of the at least one suction/infusion catheter;
a first configuration when the at least one suction/infusion catheter is at least partially extended from a delivery catheter; and
a second configuration when the at least one suction/infusion catheter is positioned within the delivery catheter, the second configuration different from the first configuration;
wherein the at least one suction/infusion catheter, when introduced into a pericardial space surrounding a heart at or near a myocardial infarct border zone, is operable to inject a glue-like substance through a lumen of the at least one suction/infusion catheter and out from the one or more apertures to deliver the glue-like substance into the pericardial space at or near the myocardial infarct border zone.

### Claim 36 (depends on 35)

The system of claim 35, wherein the at least one suction/infusion catheter is further operable to inject magnetic cells through the lumen of the at least one suction/infusion catheter and out from the one or more apertures to deliver the magnetic cells into the pericardial space at or near the myocardial infarct border zone, wherein the magnetic cells are attracted to the glue-like substance, and wherein the magnetic cells provide structural support to the myocardial infarct border zone.

### Claim 37 (depends on 35)

The system of claim 35, wherein the first configuration comprises a coiled configuration, and wherein the second configuration comprises an uncoiled configuration.
